Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

August 1, 2019; Volume 60,Issue 8
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Adumeau, Pierre

    1. You have access
      The Impact of FcγRI Binding on Immuno-PET
      Delphine Vivier, Sai Kiran Sharma, Pierre Adumeau, Cindy Rodriguez, Kimberly Fung and Brian M. Zeglis
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1174-1182; DOI: https://doi.org/10.2967/jnumed.118.223636
  2. Albertsson, Per

    1. You have access
      Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations
      Andreas Hallqvist, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, Holger Jensen, Lars Jacobsson, Ragnar Hultborn, Stig Palm and Per Albertsson
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1073-1079; DOI: https://doi.org/10.2967/jnumed.118.220384
  3. Alizadeh, Elahe

    1. You have access
      Preclinical Evaluation of 111In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models
      Siddesh V. Hartimath, Elahe Alizadeh, Viswas Raja Solomon, Rufael Chekol, Wendy Bernhard, Wayne Hill, Angel Casaco Parada, Kris Barreto, Clarence Ronald Geyer and Humphrey Fonge
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1103-1110; DOI: https://doi.org/10.2967/jnumed.118.220095
  4. Alonso, Omar

    1. You have access
      Is True Whole-Body 18F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study
      Juliano J. Cerci, Elba C. Etchebehere, Helen Nadel, Anita Brink, Chandrasekhar S. Bal, Venkatesh Rangarajan, Thomas Pfluger, Olga Kagna, Omar Alonso, Fatima K. Begum, Kahkashan Bashir Mir, Vincent P. Magboo, Leon J. Menezes, Diana Paez and Thomas N. Pascual
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1087-1093; DOI: https://doi.org/10.2967/jnumed.118.222299
  5. Ametamey, Simon M.

    1. You have access
      Preclinical Evaluation of Benzazepine-Based PET Radioligands (R)- and (S)-11C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and a Tightrope Walk Between GluN2B- and σ1-Receptor–Targeted PET Imaging
      Achi Haider, Adrienne Müller Herde, Stefanie D. Krämer, Jasmine Varisco, Claudia Keller, Katrin Frauenknecht, Yves P. Auberson, Louisa Temme, Dina Robaa, Wolfgang Sippl, Roger Schibli, Bernhard Wünsch, Linjing Mu and Simon M. Ametamey
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1167-1173; DOI: https://doi.org/10.2967/jnumed.118.221051
  6. An, Hongyu

    1. Open Access
      Measurement Repeatability of 18F-FDG PET/CT Versus 18F-FDG PET/MRI in Solid Tumors of the Pelvis
      Tyler J. Fraum, Kathryn J. Fowler, John P. Crandall, Richard A. Laforest, Amber Salter, Hongyu An, Michael A. Jacobs, Perry W. Grigsby, Farrokh Dehdashti and Richard L. Wahl
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1080-1086; DOI: https://doi.org/10.2967/jnumed.118.218735
  7. Andersson, Håkan

    1. You have access
      Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations
      Andreas Hallqvist, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, Holger Jensen, Lars Jacobsson, Ragnar Hultborn, Stig Palm and Per Albertsson
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1073-1079; DOI: https://doi.org/10.2967/jnumed.118.220384
  8. Auberson, Yves P.

    1. You have access
      Preclinical Evaluation of Benzazepine-Based PET Radioligands (R)- and (S)-11C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and a Tightrope Walk Between GluN2B- and σ1-Receptor–Targeted PET Imaging
      Achi Haider, Adrienne Müller Herde, Stefanie D. Krämer, Jasmine Varisco, Claudia Keller, Katrin Frauenknecht, Yves P. Auberson, Louisa Temme, Dina Robaa, Wolfgang Sippl, Roger Schibli, Bernhard Wünsch, Linjing Mu and Simon M. Ametamey
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1167-1173; DOI: https://doi.org/10.2967/jnumed.118.221051
  9. Back, Tom

    1. You have access
      Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations
      Andreas Hallqvist, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, Holger Jensen, Lars Jacobsson, Ragnar Hultborn, Stig Palm and Per Albertsson
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1073-1079; DOI: https://doi.org/10.2967/jnumed.118.220384
  10. Bal, Chandrasekhar S.

    1. You have access
      Is True Whole-Body 18F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study
      Juliano J. Cerci, Elba C. Etchebehere, Helen Nadel, Anita Brink, Chandrasekhar S. Bal, Venkatesh Rangarajan, Thomas Pfluger, Olga Kagna, Omar Alonso, Fatima K. Begum, Kahkashan Bashir Mir, Vincent P. Magboo, Leon J. Menezes, Diana Paez and Thomas N. Pascual
      Journal of Nuclear Medicine August 1, 2019, 60 (8) 1087-1093; DOI: https://doi.org/10.2967/jnumed.118.222299
« Previous (Pages : 1 2 3 4 5 6 ... 23) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (8)
Journal of Nuclear Medicine
Vol. 60, Issue 8
August 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer 11C-AS2471907 in Human Brain
  • Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma
  • Evaluation of 11C-LSN3172176 as a Novel PET Tracer for Imaging M1 Muscarinic Acetylcholine Receptors in Nonhuman Primates
  • Development of Dedicated Brain PET Imaging Devices: Recent Advances and Future Perspectives
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire